Tharimmune, Inc. Quarterly Operating Income (Loss) in USD from Q1 2021 to Q2 2024
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Tharimmune, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q1 2021 to Q2 2024.
- Tharimmune, Inc. Operating Income (Loss) for the quarter ending June 30, 2024 was -$2.37M, a 0.38% decline year-over-year.
- Tharimmune, Inc. Operating Income (Loss) for the twelve months ending June 30, 2024 was -$9.1M, a 1.38% decline year-over-year.
- Tharimmune, Inc. annual Operating Income (Loss) for 2023 was -$9.46M, a 37.4% decline from 2022.
- Tharimmune, Inc. annual Operating Income (Loss) for 2022 was -$6.88M, a 115% decline from 2021.
- Tharimmune, Inc. annual Operating Income (Loss) for 2021 was -$3.21M, a 77.4% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)